[Search for the pathogenesis of multiple sclerosis from the bedside]

Area of Science:

• Neuroimmunology
• Central Nervous System (CNS) Diseases
• Autoimmune Disorders

Context:

• Multiple sclerosis (MS) is a chronic CNS demyelinating disease.
• Neuromyelitis optica (NMO) is an inflammatory CNS disease affecting optic nerves and spinal cord.
• The distinction between MS and NMO has been debated, with differing pathological hallmarks.

Purpose:

• To differentiate the underlying mechanisms and pathological characteristics of MS and NMO.
• To explore the role of T helper 17 (Th17) cells and NMO-IgG targeting aquaporin-4 (AQP4) in CNS autoimmunity.
• To investigate hypotheses regarding NMO being distinct from MS, possibly driven by anti-AQP4 antibodies.

Summary:

• MS pathology shows demyelination with preserved axons, while NMO involves both axons and myelin, leading to necrosis.
• NMO-IgG targeting astrocyte foot processes (AQP4) suggests NMO is distinct from MS.
• Alternative hypothesis suggests MS/NMO involves myelin-specific T cells, with autoantibodies modifying the disease course.
• Anti-myelin antibodies cause widespread demyelination, whereas anti-AQP4 antibodies induce astrocyte injury, edema, and necrosis.

Impact:

• Advances understanding of CNS autoimmune diseases like MS and NMO.
• Highlights the importance of identifying specific autoantigens (e.g., AQP4) in disease classification.
• Suggests future research should focus on both T cell and humoral immunity to elucidate MS pathophysiology.